https://www.selleckchem.com/pr....oducts/nor-noha-dihy
12 per 100 000 population (95% CI 0.11-0.13) . Conclusion This study firstly analyzed the epidemiological characteristics of PCL in China, which can provide evidence for the research and policies regarding PCL. Cholangiocarcinoma (CCA) is a rare but aggressive disease with a poor survival. Recent trials have shown improved survival with intraductal radiofrequency ablation (RFA) therapy. We performed a systematic review with meta-analysis to determine the survival benefit of endoscopic RFA for unresectable extrahepatic C
Like
Comment
Share
